… review, immunotherapy is an efficient therapeutic option intervention against COVID-19 and the … and plasma therapy have improved clinical outcomes in COVID-19 infected patients. …
… administration, passive immunotherapy by convalescent … immunotherapeutic approaches that will be mentioned in this review. The focus would be on passive immunotherapeutic …
… Passive immunotherapy has been used as a reliable treatment option for many infectious … , and immunogenicity of passive immunotherapy for the treatment of COVID-19. As of now on 9 …
… strategies that are supported in expert guidelines, such as anti-IL-6R blockade and corticosteroids; however, we will augment this guidance with possible treatment options for when …
… treatments as a kind of passive immunotherapy may be appropriate to achieve COVID-19 treatment [66]. In this section, immunotherapy based on the antibody include neutralizing …
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
… clinical data on the immunopathogenesis of the COVID‐19 and review the innate and adaptive … immunotherapies as well as reviewing recruiting/completed clinical trials of COVID‐19. …
… for patients with severe COVID-19 disease. A special focus has … immunotherapeuticoptions to ameliorate cytokine storm and inflammatory responses in patients affected with COVID-19…
… Most of the therapeutic options that are available for managing COVID-19 are based … COVID-19. Citation16 The major therapeutic drugs that might be effective in managing COVID-19 …
… TCZ is considered a pharmaceutical option for treating patients with COVID-19, however, during the treatment procedures, clinicians should evaluate the safety and efficacy of TCZ. …